Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–50 of 3457 results
Advanced filters: Author: Sarah B. Ng Clear advanced filters
  • The contribution of ether lipid species in cancer cell fate has not been fully understood yet. Here the authors show that malignant cancer cells employ ether lipids to modulate membrane biophysical properties, enhancing iron endocytosis and ferroptosis susceptibility.

    • Ryan P. Mansell
    • Sebastian Müller
    • Whitney S. Henry
    ResearchOpen Access
    Nature Communications
    P: 1-19
  • Approved antibody–drug conjugates (ADCs) remain constrained by a limited repertoire of payloads with restricted modes of action. Here, the authors present phosphoramidate-based self-immolative linker units that facilitate stable attachment in serum and traceless drug release in the target cell from aliphatic and aromatic alcohols with various modes of action.

    • Philipp Ochtrop
    • Anil P. Jagtap
    • Marc-André Kasper
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-13
  • Polyamines prevent the action of kinases on acidic phosphorylatable motifs in spliceosomal proteins, thus providing a mechanism for metabolite-mediated regulation of alternative splicing in cells.

    • Amaia Zabala-Letona
    • Mikel Pujana-Vaquerizo
    • Arkaitz Carracedo
    ResearchOpen Access
    Nature
    P: 1-10
  • A platform using matched patient-derived lung tumouroids and healthy lung organoids enables accurate examination of patient responses to CAR T therapy and offers a faithful framework for improved CAR T design.

    • Lukas Ehlen
    • Martí Farrera-Sal
    • Michael Schmueck-Henneresse
    ResearchOpen Access
    Nature Biomedical Engineering
    P: 1-17
  • A WHO-supported pre−post study shows that implementation of the Y-Check comprehensive health check program is feasible and acceptable for adolescents in Zimbabwe, offering screening for 25 health conditions and behaviors, health promotion, on-site care and referral.

    • Aoife M. Doyle
    • Farirai Nzvere
    • Rashida A. Ferrand
    ResearchOpen Access
    Nature Medicine
    P: 1-11
  • There is a need for an easy-to-use clinical tool, that could predict favorable early PSA response and subsequently enhance early risk stratification, as well as guide treatment planning. Here, the authors show that based on patient data from four phase III randomized trials, Nadir androgen receptor pathway inhibitor (APRI)- Derived Integrative Response (NADIR) model predicts favorable early PSA response to ≤0.2 ng/mL by 6 months in metastatic hormone sensitive prostate cancer (mHSPC) patients initiating treatment with an APRI.

    • Soumyajit Roy
    • Yilun Sun
    • Daniel E. Spratt
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-10
  • CSF total tau (t-tau), often used as a marker of neuronal damage, is more strongly linked to synaptic degeneration. Here, the authors show that t-tau better reflects synaptic dysfunction than axonal or neuronal loss in Alzheimer’s disease.

    • Carolina Soares
    • Bruna Bellaver
    • Tharick A. Pascoal
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-10
  • After spinal cord injury, lesion-remote astrocytes acquire heterogeneous, spatially restricted reactivity states that shape neuroinflammation, neural repair and neurological recovery.

    • Sarah McCallum
    • Keshav B. Suresh
    • Joshua E. Burda
    ResearchOpen Access
    Nature
    Volume: 649, P: 959-970
  • Early results from the phase 2b VIBRANT-HD trial of the oral splicing modulator branaplam in Huntington’s disease suggested reduced cerebrospinal fluid huntingtin levels, but safety monitoring revealed signs of peripheral neurotoxicity, prompting early termination of the study.

    • Beth Borowsky
    • Harry Ramos
    • Blair R. Leavitt
    ResearchOpen Access
    Nature Medicine
    Volume: 32, P: 103-112
  • Genetic variants of TREX1, a negative regulator of type I interferon responses, have been linked previously to non-monogenic systemic lupus erythematosus (SLE). Here the authors analyze UK Biobank multi-omics data to show that, while a derived oligoprotein interferon signature associates with increased SLE risk, TREX1 variants do not.

    • Bastien Rioux
    • Sarah McGlasson
    • David P. J. Hunt
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-15
  • Neutrophils infiltrate glioblastomas with the capacity to engage pro/anti tumoural responses. Here the authors developed proteomic workflows to stratify neutrophil heterogeneity by function. This work provides a platform to study neutrophil proteomes with single cell resolution in glioblastoma.

    • Pranvera Sadiku
    • Alejandro J. Brenes
    • Sarah R. Walmsley
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-17
  • High-depth sequencing of non-cancerous tissue from patients with metastatic cancer reveals single-base mutational signatures of alcohol, smoking and cancer treatments, and reveals how exogenous factors, including cancer therapies, affect somatic cell evolution.

    • Oriol Pich
    • Sophia Ward
    • Nicholas McGranahan
    ResearchOpen Access
    Nature
    P: 1-11
  • An analysis of 24,202 critical cases of COVID-19 identifies potentially druggable targets in inflammatory signalling (JAK1), monocyte–macrophage activation and endothelial permeability (PDE4A), immunometabolism (SLC2A5 and AK5), and host factors required for viral entry and replication (TMPRSS2 and RAB2A).

    • Erola Pairo-Castineira
    • Konrad Rawlik
    • J. Kenneth Baillie
    ResearchOpen Access
    Nature
    Volume: 617, P: 764-768
  • Understanding the mechanisms underlying the survival of drug tolerant persister cells following chemotherapy remains elusive. Here, multi-omics analysis and experimental approaches show that the germ-cell-specific H3K4 methyltransferase PRDM9 promotes metabolic rewiring in glioblastoma stem cells.

    • George L. Joun
    • Emma G. Kempe
    • Lenka Munoz
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-30
  • Cas9 DNA targeting is inherently sequence specific but not temporally controlled. Here, authors spatiotemporally couple Cas9 activity to target site transcription in eukaryotes and exploit this to preferentially edit the more highly transcribed of two alleles that harbor identical Cas9 targets.

    • Gregory W. Goldberg
    • Manjunatha Kogenaru
    • Jef D. Boeke
    ResearchOpen Access
    Nature Communications
    Volume: 15, P: 1-19
  • The authors find that TDP-43 loss of function—the pathology defining the neurodegenerative conditions ALS and FTD—induces novel mRNA polyadenylation events, which have different effects, including an increase in RNA stability, leading to higher protein levels.

    • Sam Bryce-Smith
    • Anna-Leigh Brown
    • Pietro Fratta
    ResearchOpen Access
    Nature Neuroscience
    Volume: 28, P: 2190-2200
  • Geminin regulates DNA replication by binding CDT1 and preventing MCM helicase loading. Using a reconstituted system and structural modelling, the authors find geminin inhibits via steric clash with MCM, not by blocking the CDT1–MCM interface. Combined with CDK activity, it fully halts licensing.

    • Joshua Tomkins
    • Lucy V. Edwardes
    • Christian Speck
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-23
  • UCHL5 is a deubiquitinating enzyme that cleaves Lys-48-linked polyubiquitin chains. Here, the authors discover through in-vivo CRISPR-Cas9 screens that Uchl5 is involved in immune evasion and modulation of extracellular matrix deposition in head and neck squamous cell carcinoma.

    • Cong Fu
    • Robert Saddawi-Konefka
    • Robert T. Manguso
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-18
  • Covalent KRAS inhibitors show initial responses but resistance limits durability. Here drug-induced hapten peptides are identified and characterized, enabling production of high affinity, cross-HLA T cell engagers that stabilize low density hapten peptide MHCs to drive tumor-specific killing.

    • Lorenzo Maso
    • Sarah A. Mosure
    • Lauren E. Stopfer
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-17
  • Whole-genome sequencing, transcriptome-wide association and fine-mapping analyses in over 7,000 individuals with critical COVID-19 are used to identify 16 independent variants that are associated with severe illness in COVID-19.

    • Athanasios Kousathanas
    • Erola Pairo-Castineira
    • J. Kenneth Baillie
    ResearchOpen Access
    Nature
    Volume: 607, P: 97-103
  • In patients with hormone receptor positive, human epidermal growth factor receptor 2-negative (HR+/HER-) breast cancer, endocrine therapy is standard of care but resistance often occurs. Here, the authors report a phase I trial investigating the ER degrader, AC699, in patients with locally advanced or metastatic ER+/HER2- breast cancer.

    • Erika Hamilton
    • Rachel M. Layman
    • Manish R. Patel
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-8
  • PU.1low CD28-expressing microglia may act as suppressive cells in Alzheimer’s disease, mitigating its progression by reducing neuroinflammation and amyloid plaque load, indicating potential immunotherapeutic approaches for treatment.

    • Pinar Ayata
    • Jessica M. Crowley
    • Anne Schaefer
    ResearchOpen Access
    Nature
    Volume: 648, P: 157-165
  • Most people who are infected with SARS-CoV-2 seroconvert within a few weeks, but the determinants and duration of the antibody response are not known. Here, the authors characterise these features of the immune response using data from a large representative community sample of the UK population.

    • Jia Wei
    • Philippa C. Matthews
    • Chris Cunningham
    ResearchOpen Access
    Nature Communications
    Volume: 12, P: 1-12
  • Species homogenisation driven by land-use intensification is threatening many taxa globally. Here, the authors find that for arthropod communities in Central Europe, managed grasslands are the most affected land-use type, while there is a strong distance–decay relationship in settlements and arable fields, meaning that these support heterogeneous communities between locations.

    • Orsi Decker
    • Johannes Uhler
    • Jörg Müller
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-15
  • This pilot trial showed that perioperative treatment with the isocitrate dehydrogenase (IDH) inhibitor safusidenib of patients with low-grade IDH-mutant glioma, with craniotomy and lumbar puncture before and after treatment, is feasible and safe and enabled in-depth translational investigation of safusidenib treatment-induced changes in the tumor, including electrophysiological effects.

    • Katharine J. Drummond
    • Montana Spiteri
    • James R. Whittle
    ResearchOpen Access
    Nature Medicine
    Volume: 31, P: 3451-3463
  • Engineering of local Anopheles gambiae under containment enables the generation of a transgenic strain equipped with non-autonomous gene drive capabilities that robustly inhibits genetically diverse Plasmodium falciparum isolates obtained from naturally infected children.

    • Tibebu Habtewold
    • Dickson Wilson Lwetoijera
    • George K. Christophides
    ResearchOpen Access
    Nature
    Volume: 649, P: 442-448
  • IL-17 signalling restricts C. albicans pathogenicity in the colonized oral cavity. Lack of IL-17 is associated with overt filamentation due to impaired zinc nutritional immunity and over time leads to the evolution of pathogenic strain variants.

    • Ricardo Fróis-Martins
    • Kontxi Martinez de San Vicente
    • Salomé LeibundGut-Landmann
    Research
    Nature Microbiology
    Volume: 11, P: 111-124
  • Variants in the PSMC5 gene impair proteasome function and cellular homeostasis, altering brain development in children. This study reveals underlying molecular mechanisms contributing to this neurodevelopmental phenotype, and suggests therapeutic leads for neurodevelopmental proteasomopathies.

    • Sébastien Küry
    • Janelle E. Stanton
    • Elke Krüger
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-21
  • Many SARS-CoV-2 infections may go undetected through conventional PCR or lateral flow tests. Here, the authors analyse the utility of analysing longitudinal nucleocapsid antibody trajectories to improve identification of prior SARS-CoV-2 infections using surveillance data from the UK.

    • Leslie R. Zwerwer
    • Tim E. A. Peto
    • Chris Cunningham
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-13
  • Evolutionary and ecological insights into marine SAR11 bacteria require whole genome data. Here, the authors expand the number of complete SAR11 isolate genomes by 81 new strains from the tropical Pacific Ocean, combining their sequence analysis with metagenomics to further resolve SAR11 evolution.

    • Kelle C. Freel
    • Sarah J. Tucker
    • Michael S. Rappé
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-14
  • The authors describe the isolation and characterization of broadly cross-neutralizing monoclonal antibodies (mAbs) against diverse H5Nx viruses from individuals who received a monovalent H5N1 vaccine 15 years ago. They identify five mAbs that potently neutralized the majority of H5 clades and protected against lethal 2.3.4.4b H5N1 infection in mice.

    • Alexandra A. Abu-Shmais
    • Gray Freeman
    • Sarah F. Andrews
    ResearchOpen Access
    Nature Microbiology
    Volume: 10, P: 2903-2918
  • Walmsley and colleagues report that systemic hypoxia induces persistent loss of histone H3K4me3 marks and epigenetic reprogramming in neutrophil progenitors, resulting in long-term impairment of subsequent neutrophil effector functions.

    • Manuel A. Sanchez-Garcia
    • Pranvera Sadiku
    • Sarah R. Walmsley
    ResearchOpen Access
    Nature Immunology
    Volume: 26, P: 1903-1915
  • A post hoc analysis of a multicentre, randomised trial showed that prediabetes remission is possible without total weight loss—providing weight is distributed to subcutaneous deposits as opposed to visceral ones.

    • Arvid Sandforth
    • Elsa Vazquez Arreola
    • Reiner Jumpertz von Schwartzenberg
    ResearchOpen Access
    Nature Medicine
    Volume: 31, P: 3330-3340
  • A global network of researchers was formed to investigate the role of human genetics in SARS-CoV-2 infection and COVID-19 severity; this paper reports 13 genome-wide significant loci and potentially actionable mechanisms in response to infection.

    • Mari E. K. Niemi
    • Juha Karjalainen
    • Chloe Donohue
    ResearchOpen Access
    Nature
    Volume: 600, P: 472-477
  • Adoptive regulatory T cell (Treg) therapy holds promise for the treatment of a range of immunopathological conditions. Here the authors explore the HLA engineering of allogenic Treg products that avoid T cell and NK cell attack and maintain immunomodulatory function in a human skin-xenograft model.

    • Oliver McCallion
    • Weijie Du
    • Fadi Issa
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-14